map, has been found to influence vitamin B12 uptake or utilization. The btuC function is required for the growth response to vitamin B12 when the outer membrane transport process (btuB or tonB function) is defective. However, even in a wild-type strain, btuC is required for proper transport of vitamin B12. Additional mutations in the vicinity of btuC were isolated as lac fusions that produced a phenotype similar to that of a btuC mutant. The btuC region was cloned by selection for complementation of a btuC mutation. Complementation testing with plasmids carrying various deletions or transposon TnlOOO insertions demonstrated that the new mutations defined a separate, independently expressed locus, termed btuD. The coding regions for both genes were identified on a 3.4-kilobase HindIll-HincII fragment and were 800 to 1,000 base pairs in length. They were separated by a 600-to 800-base-pair region. The gene order in this portion of the chromosome map was found to be pps-zdh-3::TnlO-btuD-btuC-pheS. Expression of Il-galactosidase in the btuD-lac fusion-bearing strains, whether proficient or defective in vitamin B12 transport, was not regulated by the presence of vitamin B12 in the growth medium.
The transport of vitamin B12 in Escheryihia coli requires a specific vitamin B12 receptor protein in the outer membrane and the tonB gene product. In addition, the btuC gene, located at min 38 on the genetic map, has been found to influence vitamin B12 uptake or utilization. The btuC function is required for the growth response to vitamin B12 when the outer membrane transport process (btuB or tonB function) is defective. However, even in a wild-type strain, btuC is required for proper transport of vitamin B12. Additional mutations in the vicinity of btuC were isolated as lac fusions that produced a phenotype similar to that of a btuC mutant. The btuC region was cloned by selection for complementation of a btuC mutation. Complementation testing with plasmids carrying various deletions or transposon TnlOOO insertions demonstrated that the new mutations defined a separate, independently expressed locus, termed btuD. The coding regions for both genes were identified on a 3.4-kilobase HindIll-HincII fragment and were 800 to 1,000 base pairs in length. They were separated by a 600-to 800-base-pair region. The gene order in this portion of the chromosome map was found to be pps-zdh-3::TnlO-btuD-btuC-pheS. Expression of Il-galactosidase in the btuD-lac fusion-bearing strains, whether proficient or defective in vitamin B12 transport, was not regulated by the presence of vitamin B12 in the growth medium.
The uptake systems for vitamin B12 and numerous ironsiderophore complexes in Escherichia coli are unusual in that they employ specific receptor proteins in the outer membrane as an essential component of the high-affinity active transport process (26) . The tonB product appears to be necessary for the energy-dependent stages of many transport processes mediated by these receptors (21, 32) . For example, whereas the uptake of vitamin B12 by means of the btuB-coded B12 receptor is tonB dependent, the entry of the E colicins and phage BF23, which use the same receptor, is not (2, 8, 13) . In addition to the receptors, other gene products have been implicated in siderophore transport at steps subsequent to receptor binding. Mutations in the fecB, fepB, iutB, and ffiuBCD loci prevent uptake of ferric citrate, ferric enterochelin, ferric aerobactin, and hydroxamate-type siderophores, respectively, but do not impair formation of the corresponding receptor (15, 20, 26, 27, 30, 31, 33) .
Mutations affecting vitamin B12 uptake in an identical manner to those blocking iron uptake have not been observed (7) . Mutations at btuC only slightly impair the growth response of metE mutants to vitamin B12 in place of methionine (3, 14) . The initial rate of vitamin B12 transport in a btuC mutant strain resembles that in wild-type strains. A steady-state level of vitamin B12 accumulation is attained, which differs from the parental situation in that most or all of the accumulated vitamin B12 can be chased from the cell upon addition of excess nonradioactive vitamin B12 (3) . Parental strains retain most of the transported substrate. The vitamin B12 accumulated in a btuC strain is not converted into the various metabolic derivatives normally found and can be released from the cell by EDTA treatment (28 Strains deficient in the components of the outer membrane transport process (altered at btuB, tonB, or both) can still utilize elevated (5 ,uM) levels of vitamin B12 (3). Receptorindependent utilization of vitamin B12 is more effective in strains with altered outer membrane barrier properties (3). In these cases, the growth response to vitamin B12 is absolutely dependent on btuC function. btuC appears to be involved solely in B12 utilization, since the btuC genotype has no effect on the response to the E colicins or phage BF23 or on the utilization of ferric-siderophore complexes as iron source (unpublished observations).
The genetic analysis of the btuC region described in this paper was prompted by the uncertainty of whether this function was involved in the transport of vitamin B12 across the cytoplasmic membrane or its intracellular processing. Only three btuC alleles were available, and it was unknown whether the dispensability of btuC function for the growth response to vitamin B12, when the outer membrane components were intact, reflected only partial loss of function in these mutants. Another impetus for this study concerned the possible role in transport of a vitamin B12-binding protein of approximately 22 ,000 molecular weight, which was released upon osmotic shock (7, 29) .
In this paper, we report the isolation of lac fusions near btuC, which define another gene involved in B12 utilization, termed btuD, and the cloning of this region. By generation of deletions between restriction endonuclease cleavage sites and subcloning procedures, the regions able to complement btuC and btuD mutations were identified and separated. These results were confirmed by the isolation of insertions of the transposon TnJ000.
MATERIALS AND METHODS
Media and chemicals. L broth and minimal medium A were as described by Miller (25) . Solid media contained 2% agar. Antibiotics were added to the following final concentrations: ampicillin, 25 ,ug/ml; tetracycline, 20 p,g/ml; and kanamycin sulfate, 40 p,g/ml. Cyanocobalamin (vitamin B12) was ob- (12) .
Construction of btuD-lacZ operon fusions. A derivative of bacteriophage X, XplacMu5O, was used to isolate the btuDlacZ operon fusion by transposition of the phage into the btuD gene (5) (Fig. 1 FIG. 1. Construction of btuD-lac operon fusions and generation of deletions. Some of the Lac + strains generated by transposition of XplacMu5O into the chromosome of a strain with a TnlO insertion near btuC (a, b) have an integrated prophage that can be transduced by phage P1 along with the tetracycline resistance of TnlO (c). A few tetracycline-resistant transductants were Lac', and a few of these exhibited a Btu-phenotype (d). Lysogenization of Lac' Btustrains with phage XplO81.1 (e) was obtained by selection for kanamycin-resistant colonies that were Lac-(f). The tandem dilysogen was unstable and gave rise to temperature-sensitive variants by homologous recombination within the prophages (g). Selection for temperature resistance yielded deletion strains (h). Most of them retained kanamycin resistance. Some were tetracycline susceptible, whereas others retained the tetracycline resistance of the TnJO. Restriction endonuclease digestions and ligations. DNA was digested with restriction endonucleases under conditions suggested by the manufacturer (Bethesda Research Laboratories). Products were analyzed on 0.8% agarose gels, and the sizes of the fragments were determined by comparison to X DNA digested with HindIII. Ligations were performed as described by Berman et al. (5) .
Cloning procedures. Chromosomal DNA was isolated from strain RK4954 and digested to completion with the restriction endonuclease PstI. With T4 DNA ligase, DNA fragments were cloned into the unique PstI site of plasmid pBR322 (24) . Hybrid plasmids containing a fragment of DNA carrying the btuC gene were isolated in strain RK4446 (metE btuB tonB btuC recA) by selection for resistance to tetracycline and ability to grow on 5 ,uM B12. Isolates were purified on selective medium. Plasmids were isolated by a miniprocedure employing alkaline sodium dodecyl sulfate extraction (6) and digested with restriction endonucleases. Transformations were carried out by the CaCl2 procedure of Dagert and Ehrlich (11) .
Southern blot analysis. Preparation of gels and transfer assembly were performed as described by Berman et al. (5) . Hybridizations were carried in Sx SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-50% formamide at 420C.
DNA used for probes was isolated as restriction fragments from agarose gels as described by Benson (4) and then nick translated with the Bethesda Research Laboratories nick translation kit as suggested by the manufacturer.
P-Galactosidase assays. P-Galactosidase production in strains carrying fusions to lacZ was assayed by monitoring change in optical density at 420 nm of o-nitrophenyl-,-galactopyranoside in Z buffer (25) . Cells were grown to the early logarithmic phase in medium A, washed three titnes, and disrupted in a French pressure cell. The specific activity of P-galactosidase was expressed as change in optical density at 420 nm per minute per 1012 cells.
Vitamin B12 transport assays. Assays of vitamin B12 transport were modified from the procedure of Kadner and Bassford (19) . Cells were grown in medium A to the early logarithmic phase, and 3H-labeled vitamin B12 was added to a final concentration of 34 nM (0.23 ,uCi/ml). At indicated times, 0.2 ml of cells was removed, delivered directly onto a membrane filter (0.45-,um pore size; Millipore Corp.), immediately washed with 5 ml of medium A, and then dried and counted. Retention of transported vitamin B12 was assayed by running a duplicate reaction and adding an excess of unlabeled vitamin B12 (0.1 ptM, final concentration) at 20 min after the addition of the labeled substrate and removing samples at 5-min intervals thereafter. Correction was made for the binding of labeled substrate to filters in the absence of cells. Uptake is expressed in picomoles per microliter of cell water.
RESULTS
Isolation of btuD-lacZ fusions. The btuC region is located at min 37.5 on the E. coli linkage map, between pheS and the TnJO insertions zdh-J and zdh-3 (1, 3, 12) . Mutations resulting from fusion to lacZ and located in the btuC region were obtained by using phage XplacMuSO, which forms stable lac fusions in a single step (9) (Fig. 1) . A P1 phage lysate prepared on a pool of lactose-utilizing lysogens was used to transduce strain RK6036 (metE btuB) to tetracycline resistance, thereby selecting for recombinants that acquired the The cI+ prophages in the btuC region were replaced with X1081.1 by homologous recombination (Fig. 1) (5) . This phage carries c1857 and lacZ::TnS, so that temperature-sensitive lysogens can be obtained by selection for kanamycinresistant strains that are Lac-. In this way thermoinducible lysogens were obtained for all four fusions with and, without the adjacent zdh-3::TnlO insertion. Selection for temperature resistance should yield deletions removing X and flanking chromosomal sequences (5).
Temperature-resistant variants were obtained at low frequency (less than 10-8). All were A sensitive, but most remained kanamycin resistant, suggesting that the deletions extended only in one direction, away from the promoter for the gene into which insertion had occurred (Fig. 1) . In transduction crosses, kanamycin resistance was 100o linked to the Btu-phenotype (data not shown). In several temperature-resistant variants that retained zdh-3::TnlO, tetracycline resistance and the Btu-phenotype were very closely linked (98 to 100%o cotransduction), in contrast to the 90% linkage between this transposon and btuC (Table 2 , crosses 16 to 19). Some of the deletions appeared to remove the adjacent zdh-3::TnJO insertion, since the strains became tetracycline susceptible. The temperature-resistant derivatives that had become tetracycline susceptible were used as recipients to examine the extent of the deletion (Fig. 2) .
When a zdh-3::TnlO btuC+ strain was used as a donor (Table  2 , cross 26; compare with cross 22), all of 100 tetracyclineresistant recombinants were Btu+. When the more distant zdh-l :TnlO insertion (70%o cotransduction with btuC) was in the donor strain, a few (6 of 100) tetracycline-resistant recombinants remained Btu-( Table 2 , cross 24). These results showed that the events resulting in formation of temperature-resistant, tetracycline-susceptible derivatives from the zdh-3::TnJO fusion-bearing strain were deletions VOL. 162, 1985 extending to or beyond the site of the zdh-3::TnJO insertion, but not as as far as the site of the zdh-::TnlO insertion.
To determine whether the deletions removed btuC, transduction crosses between a donor carrying zdh-3::TnlO btuC and various deletion strains were performed (Fig. 2b) . If the deletion included the site of the btuC mutation, all tetracycline-resistant transductants must be Btu-. If the deletion did not cover the site of the btuC mutation, recombination could occur between the endpoint of the deletion and the btuC mutation to give rise to Btu' transductants. In all crosses (Table 2, crosses 21, 23, 25, and 27 ), approximately 5% of the tetracycline-resistant recombinants were Btu+. Thus, the deletions did not cover the site of the btuC mutation in the donor strain. This result and those presented below demonstrated that the fusions were in a gene distinct from btuC. This gene is termed btuD and, on the basis of the mapping and deletion results, lies in the gene order zdh-3-btuD-btuC-pheS (Fig. 3) .
Phenotype of btfD mutants. When resident in a metE tonB btuB strain, the btuD fusions and deletions conferred a less severe impairment of vitamin B12 utilization than did a btuC mutation. Deficiency at btuC resulted in complete inability to utilize vitamin B12 in place of methionine. The presence of the btuD fusions and deletions in this genetic background resulted in markedly decreased growth with 5 ,uM B12 after 18 h, but full growth after 48 h. Growth on minimal medium with methionine appeared normal.
In strains wild type at btuB and tonB, the presence of the btuC mutation prevented growth on 0. 3 . Distances between markers, judged from transduction frequencies. The distances (in kb) between the markers depicted in this graphic were estimated by conversion of cotransduction frequencies into distances using the formula of Wu (33) . The values are approximate because of the small number of recombinants examined and the high cotransduction frequencies. However, subcloning and nucleotide sequence information places the distance between btuC and btuD at 1.6 to 2.4 kb. nMvitamin B12 and showed reduced growth on 0.5 nM vitamin B12. This difference in growth phenotype supported the view that the deletions left btuC intact.
The vitamin B12 uptake properties of these strains were determined (Fig. 4) . Both the btuC and btuD mutations had a similar effect on transport activity. The initial phases of uptake were similar to that in the parental strain. In both mutant strains, a steady-state level of vitamin B12 accumulation lower than that in the parental strain was reached. Most of the accumulated substrate was released from the mutant strains upon addition of excess nonradioactive vitamin B12. In the parental strain, a larger proportion of the accumulated label was retained under these conditions.
Cloning of the btuC region. To investigate the genetic organization of the btuC region, its molecular cloning was undertaken. A library of PstI-digested chromosomal DNA from strain RK4954 was constructed in pBR322 and was introduced into strain RK4446 (metE tonB btuB btuC recA). Tetracycline-resistant transformants were screened for growth on minimal medium with 5 ,uM B12. Two btuC+ Deletions were generated by digestion with the appropriate restriction enzyme and self-ligation. The plasmid sequences are not indicated. The ability of each plasmid to complement recA btuC or btuD recipients for growth with vitamin B12 is indicated on the right. transformants contained plasmids that carried a common 8-kb PstI fragment, whose restriction endonuclease cleavage sites were mapped. As diagrammed in Fig. 5 , a variety of deletions between restriction sites and subclones carrying portions of the 8-kb PstI insert were constructed. The details of the subcloning of some of the restriction fragments are not shown, but involved the addition of restriction site linkers and cloning into the polylinker region of plasmid pUC9, so that the fragments contained HindIII or EcoRI sites at their ends. This allowed cloning into the appropriate sites of pBR322. Several of the inserts were also cloned into the phage vector, XNEM540.
The complementation properties of the plasmids described in Fig. 5 were determined by introducing them by transformation into recA btuB derivatives of btuC or btuD strains. Transformants were tested for growth on 5 ,uM B12. Plasmid pLCD2, carrying the 8-kb PstI fragment, complemented all btuC and btuD mutations, including AbtuD deletions. Deletion of the 1.5-kb PstI-HindIII fragment in pLCD29 did not affect complementing activity. Deletion of either the SstII fragment (pLCD8) or the larger overlapping BglII fragment (pLCD7) abolished btuC-complementing activity, but with retention of btuD-complementing activity. The smallest fragment capable of complementing both btuC and btuD was the 3.4-kb HindIII-HincII fragment (pLCD25 and others). Within this 3.4-kb fragment (Fig. 5) , btuC must lie to the left side, since the 1.4-kb HindIII-EcoRV fragment (pLCD12 and others) complemented btuC, whereas the 1.0-kb HindIIIBglII fragment (pLCD16) did not. The btuD gene lies on the right side of the 3.4-kb fragment, since the 2.4-kb BglIIHincII fragment (pLCD27) complemented btuD, whereas the 2.2-kb HindIII-BalI fragment (pLCD26) did not. Note that btuC and btuD were expressed even when the appropriate fragments were cloned separately in either orientation in the vector, suggesting that they comprise separate transcription units.
Chromosomal origin of the cloned genes. The approach of Greener and Hill (16) was employed to show that the cloned genes were derived from the btuC region of the chromosome. Plasmid pUC9 and its derivative, pLCD4, carrying the 3.4-kb HindIII-HincII fragment, were introduced into strain RK5721. This strain carries the polA mutation, which prevents autonomous replication of ColEl-like plasmids (23) . Selection for maintenance of the plasmids' ampicillin resistance determinant requires integration of the plasmid into the chromosome, preferentially by homologous recombination at the site on the chromosome from which the cloned DNA originated. Genetic crosses were conducted to reveal the location of the integrated drug resistance determinant and thereby the origin of the cloned fragment. Phage P1 lysates of ampicillin-resistant transformants were used to infect strain RK6210 (pheSII zdh-3::TnlO). Ampicillin-resistant transductants were tested for their response to tetracycline and to p-fluorophenylalanine, specified by the pheSI I allele present in the recipient strain. When the donor strain carried the vector pUC9, all of the ampicillin-resistant trans ductants remained resistant to tetracycline and p-fluorophenylalanine. When the donor strain carried plasmid pLCD4, 35% of the ampicillin-resistant transductants were susceptible to tetracycline and 55% were susceptible to p-fluorophenylalanine. These results showed that plasmid pLCD4 had integrated into the btuCD region of the chromosome and hence must carry DNA derived from that region.
Physical location of the btuC and btuD mutations. The location of btuC on the 3.4-kb HindIII-HincII fragment was determined by marker rescue experiments testing the ability of plasmids carrying portions of the 3.4-kb insert to yield btuC+ recombinants when introduced into a strain carrying the btuC456 allele. Plasmid pLCD16, carrying the 1.0-kb HindIII-BglII fragment, did give rise to btuC+ recombinants. In contrast, neither plasmid pLCD27, carrying the 2.4-kb BglII-HincII fragment, nor plasmid pLCD33, carrying the region from the leftward PstI terminus to the BalI site but deleted between the SstII sites, gave any btuC+ recombinants, even after prolonged incubation of the selection plates. These results placed the location of the btuC456 mutation in the 660-base-pair (bp) region between the HindIII site and the rightward SstII site.
The location of the btuD gene could not be determined by marker rescue crosses because of the leaky phenotype of btuD fusion or deletion strains on minimal medium with vitamin B12. However, the approximate location of the sites of the insertions could be determined by Southern hybridization analysis (data not shown). Chromosomal DNA from btuD-lacZ fusion-bearing strains and the parental strain was digested with EcoRV, separated by agarose gel electrophoresis, transferred to nitrocellulose filters, and probed with the 32P-labeled, 3.4-kb HindIII-HincII fragment. Three EcoRV fragments from the parental strain hybridized to the 3.4-kb probe, as expected from the restriction map in Fig. 5 hybridization to the central 1.4-kb EcoRV fragment was disrupted and replaced by hybridization to fragments of different sizes in the different insertions.
DNA from strains carrying btuD deletions was analyzed in the same manner. Hybridization to the 2.9-kb EcoRV fragment, which contains btuC, still occurred. The 1.4-kb and 3.2-kb EcoRV fragments no longer hybridized and were replaced by other fragments of various sizes. These results were in agreement with the complementation behavior and showed that the btuC and btuD genes were separated by the EcoRV site at the 3.0-kb coordinate defined in Fig. 5 . Insertions between btuC and btuD allowed the expression of both genetic activities. This region could be as large as 600 to 800 bp and thus could encode another protein.
Effect of btuCD plasmids on B12 uptake. Vitamin B12 transport activity in strains carrying the btuCD+ plasmid pLCD2 was determined (Fig. 7) . The presence of this plasmid resulted in elevated uptake rates in both btuC+ and btuC strains, relative to these strains with or without the vector plasmid pBR322. Addition of nonradioactive vitamin B12 resulted in extensive loss of label in the btuC mutant. This chase did not occur when this strain carried plasmid pLCD2. Thus, this plasmid was able to complement a btuC mutant both for ability to retain B12 and with amplification of uptake activity.
Regulation of btuD expression. The expression of the btuB-coded receptor protein is subject to repression by growth with vitamin B12 (18) . To examine whether btuD expression was also regulated in this manner, ,-galactosidase production by strains carrying the four btuD-lac operon fusions was determined. These strains were made lysogenic for phage X540btuCD', which carries the 3.4-kb btuCD region, to restore normal vitamin B12 transport activity. All four btuD-lac fusion-bearing strains, grown without or with 1 ,uM vitamin B12, exhibited approximately the same levels of 3-galactosidase (near 100 U) ( Table 3) . By contrast, the 3-galactosidase activity of a strain carrying a btuB-iacZ operon fusion was in this range, but was repressed 3.4-fold by growth with 1 ,uM vitamin B12. Thus, the expression of btuD appears not to be regulated by vitamin B12 levels in the growth medium.
DISCUSSION
This paper provides an initial characterization of genes in the btuC region which are involved in the transport or utilization of vitamin B12. Mutant isolation and complementation tests with subclones and Tn1000 insertions showed that at least two genes located in this region contribute to this function. The complementation analysis involving transformation of btuC or btuD mutant strains with various plasmids allowed the physical localization of the coding region for these genes on a 3.4-kb DNA segment. The two genes were expressed independently, and transposon insertions in one did not impair the expression of the other. This result showed that btuC and btuD are not part of the same transcription unit. The basic complementation results have been confirmed by using DNA fragments cloned into a X vector and maintained at single copy, showing that the observed complementation behavior was not an aberration resulting from high dosage of these genes.
Strains carrying either the 8-kb PstI fragment or the 3.4-kb HindIlI-HinclI fragment in multicopy plasmids exhibited elevated rates of vitamin B12 uptake. Retention of accumulated substrate was observed even when the host carried the btuC mutation. This result suggested that the cloned 3.4-kb fragment carries all of the genes in this vicinity that contribute to the uptake activity. The increase in the rate of transport was not proportional to the increase in gene copy number. However, the transport process is complex, involving in addition the outer membrane receptor and the tonB product. The site of the rate-limiting step is not known, but is probably not the transport across the cytoplasmic membrane. These results do not rule out a role for the products of btuC or btuD or both in the metabolic conversions of vitamin B12, rather than its transport across the cytoplasmic membrane. Perhaps elucidation of the cellular location of these polypeptides might be informative.
The btuD mutations isolated in this study resulted from insertion of the transposable element XplacMuSO (9), which allows single-step formation of lac fusions to the target gene. Fusions in the btuC region were selected on the basis of the cotransduction of their Lac' character with a TnlO insertion near btuC. The fusions obtained in this manner could be transduced into other strains without serious problems from induction of the prophage or further transposition. The four fusions obtained were all to the btuD gene. Despite the fact that insertion of the X prophage or deletions from the site of the prophage probably result in complete loss of this gene function, the phenotype of these mutants with respect to growth with B12 was markedly less severe than the phenotype of btuC mutants. This indicates that the btuD product is not essential for B12 utilization, even in strains lacking the outer membrane transport system. When assayed by uptake of labeled vitamin B12, both btuC and btuD mutants have essentially identical transport properties. The growth response to vitamin B12 is a more sensitive assay than is uptake of labeled substrate, since uptake of as few as 25 molecules per cell per generation is sufficient to allow full growth (14) .
Some of the deletions generated from the fusion strain retained kanamycin resistance, but had lost X sequences and the adjacent zdh-3 insertion. The simplest explanation is that the direction of transcription of btuD is toward zdh-3 because the kanamycin resistance determinant lies between the btuD promoter and the X sequences. Since these deletions did not remove btuC, btuC must lie on the other side of btuD from zdh-3. Hence the gene order in this region has to be zdh-3-btuD-btuC-pheS.
Recent observations (unpublished) showed that three polypeptides are encoded in the btuC region, showing that the region between btuC and btuD does encode a protein. It is not possible to prove yet that the product of this middle gene is also involved in B12 uptake, since chromosomal mutations have not yet been obtained in this gene. Attempts are being made to cross the TnJOOO insertions in this gene onto the chromosome to examine the B12 growth phenotype of these mutants.
